Cardiovascular Health Topics

The On-Topic Netowork

Cardiovascular Health > Anticoagulant


Anticoagulant
Anticoagulant
Anticoagulant
Anticoagulant
Anticoagulant

The following information is about Anticoagulant.

Anticoagulant Defined

A family of medications which thins the blood and prevents the formation of clots in the blood. Anticoagulants can also dissolve clots that previously blocked blood flow in the coronary arteries.

This definition is in context to Cardiovascular Health. See more contextual defintions for Anticoagulant.


Navigation: [ 1 2 Next ]

Little suckers clear the path to the brain

Published September 5, 2008, 7:22 am, Goulburn Post

WHEN Mehdi Jaffari was told his left carotid artery was so severely blocked he faced the risk of an imminent stroke, he turned the clock back to medieval times.

Full Story


Major Bleeding Has Significant Impact And Contributes To 30-Day Mortality Following Angioplasty In Severe Heart Attack ...

Published September 5, 2008, 4:16 am, Medical News Today

The Medicines Company (NASDAQ: MDCO) announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty.

Full Story


Sitting Tight in September

Published September 4, 2008, 11:27 am, The Motley Fool

Some drugmakers await big news from the FDA this month.

Full Story


Results Of The APPRAISE-I Dose Guiding Trial

Published September 4, 2008, 6:09 am, Medical News Today

While the results of the study did not show a statistically significant difference in ischemic events among any of the four doses of apixaban evaluated, trends emerged that support further study, according to researchers at the Duke Clinical Research Institute. Apixaban targets the activity of Factor Xa, one of several enzymes involved in process of blood coagulation.

Full Story


Secondary Prevention In Acute Coronary Syndrome - Rivaroxaban Phase II Data In ACS To Be Presented At AHA Congress In ...

Published September 4, 2008, 4:11 am, Medical News Today

The development of Xarelto® (rivaroxaban), a novel oral anticoagulant, has taken another step forward. Phase II results in patients with acute coronary syndrome (ACS) have been chosen for the Late Breaking Clinical Trial session at the American Heart Association's (AHA) upcoming Annual Meeting in New Orleans, USA. The presentation will be held on November 10th, 2008 by C. Michael Gibson, M.D.

Full Story


Regado Biosciences Reports Clinical Results For REG1 Anticoagulation System At European Society Of Cardiology Congress ...

Published September 4, 2008, 3:10 am, Medical News Today

Regado Biosciences, Inc. announced the presentation of comprehensive results from Phase Ia, Ib and Ic studies of the Company's REG1 Anticoagulation System at the European Society of Cardiology's Congress 2008, currently being held in Munich, Germany.

Full Story


New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality ...

Published September 3, 2008, 9:24 am, Centre Daily Times

The Medicines Company (NASDAQ:MDCO) today announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty. This analysis of ST-elevation myocardial infarction (STEMI) patients was presented at the European ...

Full Story


New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality ...

Published September 3, 2008, 9:00 am, Business Wire via Yahoo! Finance

PARSIPPANY, N.J.----The Medicines Company today announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty.

Full Story


Results of the APPRAISE-I dose guiding trial

Published September 2, 2008, 8:26 am, EurekAlert!

( European Society of Cardiology ) Data from a phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy.

Full Story


Investigational Factor Xa Compound: Data Presented At European Heart Meeting

Published September 2, 2008, 7:08 am, Medical News Today

Data from a Phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy, according to researchers at the Duke Clinical Research Institute.

Full Story


Navigation: [ 1 2 Next ]

Are you looking for additional Cardiovascular Health > Anticoagulant news? Try our new "Anticoagulant News Focus" area.

Off-site Anticoagulant Links, User Submitted

The following links have been collected through user bookmark submission in the Anticoagulant category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Wed Aug 20

Fri Jul 18

Mon May 19

Mon May 5

Wed Apr 30

Thu Feb 21

Fri Nov 23

Mon Nov 12

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Anticoagulant. If you would like to find related tags we recommend Tag Patterns > Anticoagulant

Off-site Anticoagulant Research Links

If you still need additional information on Anticoagulant then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cardiovascular Health

If you know the Cardiovascular Health Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cardiovascular-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a